Clinical trial

Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis

NCT00667758

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-05-01

PhasePHASE2

Study timeline

Study start (unknown)2008-05-01Date precision: month

Registry last updated2012-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

CetrorelixDRUG · verified · RxNorm: cetrorelix

PlaceboDRUG

Sponsors & collaborators

Betanien Hospitallead sponsor

Norwegian Foundation for Health and Rehabilitationcollaborator

University of Oslocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00667758 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.